Vaccines: Advancements

The global market overview of antiviral drugs, therapies and vaccines is categorized depending on antivirals like Hepatitis-C, HIV , Herpes, Hepatitis-B, Influenza and other antivirals. Some of the crucial aspects that drive the antiviral markets are advances in R&D activities, augmentation in healthcare concerns, awareness and expenditure, increased pervasiveness of ominous viral diseases. According to the market reports, the global antiviral industry- therapies, drugs and vaccines was net worth $4.1 billion for 2013, and it is estimated to reach nearly $6 billion in 2018, growing at a CAGR of 8% in the forecast period of 2013-2018.

Antiviral drugs and vaccines are a class of antimicrobials, which also includes antibiotics and drugs which are solely monoclonal antibodies. Unlike antibacterials, most antivirals are relatively harmless and can be used to treat numerous viral infections. 

  • Classification of viral infections
  • Different therapies and therapeutic agents
  • HIV- AIDS
  • Advanced techonlogies in vaccines

Related Conference of Vaccines: Advancements

Vaccines: Advancements Conference Speakers